Zydus Cadila has disclosed that the company has received a warning letter from the US Food and Drug Administration relating to its Moraiya formulation facility, based in Gujarat, India. After the warning letter, the firm’s shares slipped a few points on the Bombay Stock Exchange.
According to Zydus, the company “has taken multiple steps after the inspection to address the observations received from the FDA...




